David Laith Rawaf
Overview
Explore the profile of David Laith Rawaf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
2484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmad S, Degiannis J, Borucki J, Pouwels S, Rawaf D, Lala A, et al.
J Acute Med
. 2024 Jun;
14(2):51-60.
PMID: 38855048
Background: Since late 2019, the global community has been gripped by the uncertainty surrounding the SARS-CoV-2 pandemic. In November 2021, the emergence of the Omicron variant in South Africa added...
2.
Cunha A, Compton K, Xu R, Mishra R, Drangsholt M, Antunes J, et al.
JAMA Oncol
. 2023 Sep;
9(10):1401-1416.
PMID: 37676656
Importance: Lip, oral, and pharyngeal cancers are important contributors to cancer burden worldwide, and a comprehensive evaluation of their burden globally, regionally, and nationally is crucial for effective policy planning....
3.
Ahmad S, Degiannis K, Borucki J, Pouwels S, Rawaf D, Head M, et al.
New Microbes New Infect
. 2023 Feb;
52:101094.
PMID: 36816491
Background: Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),causative pathogen of coronavirus disease 2019 (COVID-19), has triggered a pandemic with challenges for health care systems around the...
4.
Haeuser E, Serfes A, Cork M, Yang M, Abbastabar H, Abhilash E, et al.
BMC Med
. 2022 Dec;
20(1):488.
PMID: 36529768
Background: Human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS) is still among the leading causes of disease burden and mortality in sub-Saharan Africa (SSA), and the world is not...
5.
Haagsma J, Charalampous P, Ariani F, Gallay A, Iburg K, Nena E, et al.
Arch Public Health
. 2022 May;
80(1):142.
PMID: 35590340
Background: Injury remains a major concern to public health in the European region. Previous iterations of the Global Burden of Disease (GBD) study showed wide variation in injury death and...
6.
Castelpietra G, Knudsen A, Agardh E, Armocida B, Beghi M, Iburg K, et al.
Lancet Reg Health Eur
. 2022 Apr;
16:100341.
PMID: 35392452
Background: Mental health is a public health issue for European young people, with great heterogeneity in resource allocation. Representative population-based studies are needed. The Global Burden of Disease (GBD) Study...
7.
Cromwell E, Osborne J, Unnasch T, Basanez M, Gass K, Barbre K, et al.
PLoS Negl Trop Dis
. 2021 Jul;
15(7):e0008824.
PMID: 34319976
Recent evidence suggests that, in some foci, elimination of onchocerciasis from Africa may be feasible with mass drug administration (MDA) of ivermectin. To achieve continental elimination of transmission, mapping surveys...
8.
Yadgir S, Owens Johnson C, Aboyans V, Adebayo O, Adedoyin R, Afarideh M, et al.
Circulation
. 2020 Apr;
141(21):1670-1680.
PMID: 32223336
Background: Nonrheumatic valvular diseases are common; however, no studies have estimated their global or national burden. As part of the Global Burden of Disease Study 2017, mortality, prevalence, and disability-adjusted...
9.
Haagsma J, Olij B, Majdan M, van Beeck E, Vos T, Castle C, et al.
Inj Prev
. 2020 Mar;
26(Supp 1):i67-i74.
PMID: 32111726
Introduction: Falls in older aged adults are an important public health problem. Insight into differences in fall-related injury rates between countries can serve as important input for identifying and evaluating...
10.
Haagsma J, James S, Castle C, Dingels Z, Fox J, Hamilton E, et al.
Inj Prev
. 2020 Jan;
26(Supp 1):i12-i26.
PMID: 31915273
Background: The epidemiological transition of non-communicable diseases replacing infectious diseases as the main contributors to disease burden has been well documented in global health literature. Less focus, however, has been...